中文
About Us
Corporate Overview
Management Team
Board of Directors
Contact Us
Our Focus
Metabolic Diseases
Exploratory Indications
Pipeline
Pipeline
Clinical Trials
Partnership
Investors
Financials & Filing
News
Careers
Investors
Financials & Filing
2025
2024
2023
2022
2021
2020
2019
2018
2025
2024
2023
2022
2021
2020
2019
2018
Voluntary Announcement - Ascletis Announces Oral and Poster Presentations on ASC47, an Adipose-Targeted, Muscle-Preserving Weight Loss Drug Candidate for Obesity at the 32nd European Congress on Obesity
2025-05-06
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2025
2025-05-06
Next Day Disclosure Return - Others
2025-04-30
Next Day Disclosure Return - Others
2025-04-29
Next Day Disclosure Return - Others
2025-04-28
Annual Report 2024
2025-04-28
Form of Proxy for the 2025 Annual General Meeting
2025-04-28
Notice of 2025 Annual General Meeting
2025-04-28
Circulars - Proposals for General Mandates to Issue Shares and Repurchase Shares, Re-Election of Retiring Directors and Notice of Annual General Meeting
2025-04-28
Notification Letter to Non-Registered Shareholders - Reminder letter regarding the Arrangement of Electronic Dissemination of Corporate Communications and Reply Form
2025-04-28
1
2
3
4
»